Tamoxifen for breast cancer: Associated endometrial cancer
Open Access
- 1 April 1990
- Vol. 65 (7) , 1463-1464
- https://doi.org/10.1002/1097-0142(19900401)65:7<1463::aid-cncr2820650702>3.0.co;2-s
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The Christie hospital adjuvant tamoxifen trial – status at 10 yearsBritish Journal of Cancer, 1988
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- TAMOXIFEN AS RISK FACTOR FOR CARCINOMA OF CORPUS UTERIThe Lancet, 1988
- Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer PatientsOncology, 1981
- CANCER OF THE UTERINE CORPUS AFTER HORMONAL TREATMENT FOR BREAST CANCERThe Lancet, 1976
- Increased Risk of Endometrial Carcinoma among Users of Conjugated EstrogensNew England Journal of Medicine, 1975
- Association of Exogenous Estrogen and Endometrial CarcinomaNew England Journal of Medicine, 1975
- Precursors of Corpus Carcinoma Estrogens and Adenomatous HyperplasiaAmerican Journal of Obstetrics and Gynecology, 1947